Glucagon-like peptide-1 (GLP-1), an endogenous insulin tropic peptide, is delivered by L-cells via food ingestion and is considered a potential treatment for diabetes when applied at effective concentrations (93). This evidence concerns the gene GCG and diabetes mellitus.